Pro/con clinical debate: It is acceptable to stop large multicentre randomized controlled trials at interim analysis for futility
Open Access
- 1 January 2004
- journal article
- Published by Springer Nature in Critical Care
- Vol. 9 (1) , 34-36
- https://doi.org/10.1186/cc3013
Abstract
A few recent, large, well-publicized trials in critical care medicine have been stopped for futility. In the critical care setting, stopping for futility means that independent review committees have elected to stop the trial early – based on predetermined rules – since the likelihood of finding a treatment effect is low. For bedside clinicians the idea of futility in a clinical trial can be confusing. In the present article, two experts in the conduct of clinical trials debate the role of futility-stopping rules.Keywords
This publication has 3 references indexed in Scilit:
- Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2004
- Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndromeCritical Care Medicine, 2002
- A Simple Algorithm for Designing Group Sequential Clinical TrialsBiometrics, 2001